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Key points
 This study represents a first step toward predicting mechanisms of sex-based arrhythmias that
may lead to important developments in risk stratification and may inform future drug design
and screening.
 Weundertook simulations to reveal the conditions (i.e. pacing, drugs, sympathetic stimulation)
required for triggering and sustaining reentrant arrhythmias.
 Using the recently solved cryo-EM structure for the Eag-family channel as a template, we
revealed potential interactions of oestrogen with the pore loop hERG mutation (G604S).
 Molecular models suggest that oestrogen and dofetilide blockade can concur simultaneously
in the hERG channel pore.
Abstract Female sex is a risk factor for inherited and acquired long-QT associated torsade
de pointes (TdP) arrhythmias, and sympathetic discharge is a major factor in triggering TdP
in female long-QT syndrome patients. We used a combined experimental and computational
approach to predict ‘the perfect storm’ of hormone concentration, IKr block and sympathetic
stimulation that induces arrhythmia in females with inherited and acquired long-QT. More
specifically, we developed mathematical models of acquired and inherited long-QT syndrome in
male and female ventricular human myocytes by combining effects of a hormone and a hERG
blocker, dofetilide, or hERGmutations. These ‘male’ and ‘female’modelmyocytes and tissues then
were used to predict how various sex-based differences underlie arrhythmia risk in the setting of
acute sympathetic nervous system discharge. The model predicted increased risk for arrhythmia
in females when acute sympathetic nervous system discharge was applied in the settings of
both inherited and acquired long-QT syndrome. Females were predicted to have protection
from arrhythmia induction when progesterone is high. Males were protected by the presence
of testosterone. Structural modelling points towards two plausible and distinct mechanisms of
oestrogen action enhancing torsadogenic effects: oestradiol interaction with hERG mutations in
the pore loop containing G604 or with common TdP-related blockers in the intra-cavity binding
site. Our study presents findings that constitute the first evidence linking structure to function
mechanisms underlying female dominance of arousal-induced arrhythmias.
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Introduction
Cardiac arrhythmia is a primary cause of mortality in
both males and females, but the risk factors associated
with some types of arrhythmias differ between the sexes.
Female sex is the dominant risk factor for acquired
long-QT-dependent arrhythmias after puberty, with at
least 70% incidence in females (Makkar et al. 1993).
Despite recognition of this fact, the specific mechanisms
underlying sex-based differences in humans are notably
understudied andhave not been comprehensively revealed
(Tadros et al. 2014; Salama & Bett, 2014). Clinical and
experimental data uniformly agree that women have
longer QT intervals than men and are more likely to
develop long-QT-dependent arrhythmias such as torsade
de pointes (TdP) (Lehmann et al. 1996; Pham et al.
2001; Rodriguez et al. 2001; Pham et al. 2002; Salama
& Bett, 2014) that can degenerate into sudden cardiac
death. Women are also susceptible to acquired long-QT
syndrome, resulting fromblock of the cardiac repolarizing
rapidly activating delayed rectifier K+ current (IKr),
through the human ether-a`-go-go-related gene (hERG)
channel arising from the KCNH2 gene.
The longerQT interval observed in women is attributed
to a reduced repolarization reserve (James et al. 2007).
Recent clinical and experimental studies suggest that this is
due to the non-genomic effects that sex steroid hormones
have on the electrical properties of the heart (Burke et al.
1997; Rodriguez et al. 2001; Bai et al. 2005; Liu et al. 2005;
Nakagawa et al. 2006; Nakamura et al. 2007; Kurokawa
et al. 2008, 2009; Sims et al. 2008; Yang et al. 2012;
Salama & Bett, 2014; Anneken et al. 2016). Oestrogen and
progesterone interact acutely with multiple subcellular
targets, altering the resultant emergent electrical activity
at the level of cells and tissues (Nakamura et al. 2007;
Yang et al. 2010; Kurokawa et al. 2015). During the
menstrual follicular phase (prior to ovulation), oestrogen
level is the highest, QT interval is longer and susceptibility
to drug-induced arrhythmias is increased. In the luteal
phase (following ovulation) progesterone is increased
and arrhythmic events associated with acquired and
inherited long-QT syndrome are reduced (Burke et al.
1997;Rodriguez et al. 2001;Nakagawa et al. 2006;Anneken
et al. 2016).
The differences in arrhythmia vulnerability during
discrete stages of the menstrual cycle are likely to reflect
the effects that sex steroid hormones have on cardiac ion
channels (Kurokawa et al. 2008; Kurokawa et al. 2009).
Oestradiol (E2) has been shown to inhibit IKr, although
the specific interaction sites have not been fully identified
(Kurokawa et al. 2008). The result of E2 interaction
with hERG is an increase in ventricular action potential
duration, consistent with the longer QT interval observed
in women during the follicular phase of the menstrual
cycle. Progesterone, on the other hand, enhances the
slow delayed rectifier K+ current (IKs), generated by
the KvLQT1 channel (encoded by the KCNQ1 gene),
through a nitric oxide-dependent signalling pathway. This
causes a decrease in ventricular action potential duration,
consistent with the shorter QT interval observed during
the luteal phase prolongation (Nakagawa et al. 2006). The
effect of progesterone is similar to the effect of the male
sex hormone testosterone, which not only enhances IKs
via a NO-dependent mechanism, but also inhibits the
inward Ca2+ current (ICa-L), both of which contribute
to a shortening of the ventricular action potential and
the QT interval in males after puberty (Bai et al.
2005).
There are also sex-based differences in the effects of
the autonomic nervous system. Increased sympathetic
or decreased parasympathetic stimulation produces a
rate-dependent decrease in ventricular action potential
duration (APD), but this effect is greater in men than
in women (Magnano et al. 2002; Nakagawa et al. 2005;
Hoeker et al. 2014). This correlates with a longer
rate-corrected QT (QTc) interval in women. Changes
in the balance of sympathetic and parasympathetic
tone contribute to many types of arrhythmias often
resulting in sudden cardiac death (Lanfranchi et al.
2010).
Long-QT syndrome type 2 patients are susceptible to
sudden arousal associated with loud noise or emotional
C© 2017 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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Table 1. Experimental data for effects of testosterone on ICa,L for males
Isoproterenol Imax (pA pF−1) V1/2 (mV) K n
Activation
ISO −24.7 + 1.9 4.9 + 0.5 5
ISO + 100 nM DHT −19.7 ± 2.1 5.3 ± 0.7
Inactivation
ISO −27.0 ± 3.6 −26.8 ± 0.6 6.3 ± 0.3 7
ISO + 100 nM DHT −19.9 ± 4.5 −28.9 ± 0.7 6.0 ± 0.2
stress (Moss et al. 1999; Wilde et al. 1999). A recent
population study noted that 82% of the observed
arousal-induced arrhythmias occurred in females (Kim
et al. 2010). In order to begin to understand why
changes in autonomic tone are more likely to contribute
to arousal-induced arrhythmias in females, we utilized
computer models from our previous work that were
based on and validated by experimental data to
reflect acute actions of physiologically relevant human
concentrations of sex steroid hormones progesterone,
oestrogen and testosterone (Nakamura et al. 2007;
Yang et al. 2010; Yang & Clancy, 2012). Here, we
extended and expanded those models, and undertook
simulations to reveal the conditions (i.e. pacing, drugs,
sympathetic stimulation) required for triggering and
sustaining reentrant arrhythmias in females in the setting
of acute sympathetic arousal. We also employed a
protein structure-based molecular docking approach to
explore thepossible interactions betweenoestrogen, hERG
mutations and hERG blocking drugs like dofetilide. Like
the hERG blocker ibutilide, which exhibits clear sex-
and menstrual cycle-dependent effects (Rodriguez et al.
2001), Pham&Rosen (2002) reported that submicromolar
concentrations of dofetilide coupled with physiological
oestrogen levels produced a substantial APD90 increase in
females compared to males.
The results of this study suggest that specific therapeutic
anti-arrhythmic strategies for women with long-QT
syndrome should be studied. The study also suggests
molecular determinants of drugs that might be especially
problematic in females. These predictions might inform
future drug design and screening.
Methods
Ethics approval
Animal use was approved by the Institutional Animal
Care and Use Committee of Tokyo Medical and Dental
University, and conformed to the principles and standards
for reporting animal experiments inThe Journal of Physio-
logy and Experimental Physiology (Grundy, 2015).
For Fig. 1 and Tables 1 and 2, experimental
methods have been reported following the MICEE
reporting standard (see www.micee.org): type: iso-
lated cardiac ventricular myocytes; sex: male; weight:
251–350 g; species: Hartley guinea pig; supplier: Saitama
Experimental Animal Supply Co. Ltd (Saitama, Japan).
Isolation procedure. Adult guinea pigs (white Hartley;
251–350 g) were deeply anaesthetized with intra-
peritoneal injection of sodium pentobarbital (50 mg g−1,
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Figure 1. Simulated and experimentally recorded IcaL data under ISO stimulations
A, effect of DHT (100 nM) on I–V curves from guinea pig ventricular myocytes (n = 5). B, experimental data
(error bars indicated by red, n = 5 for each case) compared to simulated relative changes of the peak ICaL to ISO
application.
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Table 2. Experimental data for effects of DHT with cAMP + OA
on ICa,L current amplitude
Normalized peak ICaL
DHT concentration Mean (%) SEM n
100 nM 85.6 2.2 4
30 nM 81.3 10.6 2
10 nM 86.7 8.3 4
1 nM 98.8 1
I.P.), and then killed by cervical dislocation. Hearts were
perfused via the aorta with warm (36 ± 1°C) and
oxygenated solutions as follows: (1) Tyrode solution
containing (in mmol l−1): 135 NaCl, 5.4 KCl, 1.8 CaCl2,
1 MgCl2, 10 glucose and 10 Hepes, pH 7.4, for 5 min;
(2) Ca2+-free Tyrode solution removing CaCl2 from the
Tyrode solution; (3) Ca2+-free Tyrode solution containing
collagenase (120 units ml−1) and albumin (1 mg ml−1),
for 18 min; and (4) low-Ca2+ Tyrode solution with
0.2 mmol l−1 CaCl2, for 5 min. At the end of the
perfusion, the ventricles were minced in No. 4 solution
to release single cells. Only the quiescent myocytes with
clear striations were used for this study.
Electrophysiological recordings. For Fig. 1. L-type Ca2+
channel currents (ICa,L) were recorded with the whole-cell
configuration of the patch-clamp technique with an
Axopatch 200B amplifier (Molecular Devices, Sunnyvale,
CA,USA). Signals were low-pass filtered at 5 kHz, sampled
at 5 kHz, and compensated for cell capacitance (no
series resistance compensation). The pCLAMP software
(version 9.0, Molecular Devices) was used to generate
voltage-pulse protocols, and for acquisition and analysis
of data. The series resistance was 7.2 ± 0.6 M, the
capacitance time constant was 2.2 ± 0.3 ms, and the
membrane capacitance was 139.3 ± 7.4 pF (n = 22).
All experiments were performed at 36 ± 1°C. Pipette
solution contained (in mmol l−1): 130 CsCl, 2 MgCl2,
5 adenosine-5′-triphosphate disodium salt, 10 Hepes, 20
TEA-Cl, 10EGTA(pH7.25 adjustedwithCsOH). External
(bath) solution contained (in mmol l−1): 135 NaCl, 5.4
CsCl, 0.53MgCl2, 2CaCl2, 5.5 glucose and5Hepes (pH7.4
adjusted with CsOH).
Effects of dihydrotestosterone (DHT) were obtained
under sympathetic nervous system (SNS) activation by
10 min dialysis of 3′,5′-cyclic adenosine monophosphate
(cAMP;0.2mmol l−1) andokadaic acid (OA;0.2μmol l−1)
or by 3 min external application of (−)-isoproterenol
(ISO) hydrochloride (0.1 μmol l−1).
To monitor peak inward ICa,L, a pre-pulse (100 ms) was
applied to –40 mV from a Vh of –80 mV to inactivate the
Na+ channels and the T-type Ca2+ channels, followed
by a 200 ms Vt change to 0 mV at 1 Hz. To obtain
Table 3. The female hormone concentrations used in the
computational model
Menstrual cycle 17β-Oestradiol Progesterone
Early follicular stage 0.1 nM 2.5 nM
Late follicular stage 1.0 nM 2.5 nM
Luteal stage 0.7 nM 40.6 nM
I–V relationships for measurement of ICa,L activation,
Vt was changed from −60 mV to 50 mV in 10 mV
increments. To generate steady state inactivation curves,
long pre-pulses (500 ms) to different voltages (−50 to
20mV)were applied to allow inactivation to reach a steady
state. Then the voltage was set to −40 mV for 10 ms to
close the channels, after which a Vt change to 10 mV for
200ms was applied to assess the state of inactivation of the
channels.
Model development. We recently developed ‘male’ and
‘female’ computational model representations of human
ventricular cardiac myocytes that include genomic-based
differences in expression of key cardiac channels with
human physiological concentrations of sex hormones
on human action potentials (O’Hara et al. 2011; Yang
& Clancy, 2012). The genomic differences were based
on measured expression levels of key cardiac ion
channel genes as well as connexin43 (underlying the
dominant gap-junction subunit) in epicardial and end-
ocardial ventricular tissue from non-diseased explanted
male and female human hearts (Gaborit et al. 2010).
We utilized these data (in construction of ‘male’ and
‘female’ humanheart cell computationalmodels by scaling
the conductances of the corresponding currents in the
O’Hara–Rudy human ventricular cellmodel (O’Hara et al.
2011) as described in Yang & Clancy (2012) (see also
Appendix Table A1). Included in themale model based on
new data (shown in Tables 1 and 2 and Fig. 1) is the effect
of the acute application of a physiological concentration of
testosterone (dihydrotestosterone, DHT) 35 nM, reflecting
normal high ranges in post-pubescent pre-senescentmales
(Dorgan et al. 2002).
Simulation of acute sex steroid hormone effects
Three distinct female models were developed that include
the hormones 17β-oestradiol (E2) (Munro et al. 1991;
Dighe et al. 2005) and progesterone (Pg) (Munro et al.
1991; Janse de Jonge et al. 2001) during the early follicular,
late follicular and luteal phases of themenstrual cycle. The
hormone concentrations used in the model simulations
and their specific sources are as shown in Table 3.
The E2 reference ranges are from Munro et al. (1991)
and Dighe et al. (2005). The Pg reference ranges (used in
C© 2017 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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Table 4. G604S mutant values
WT Mutation
GKr 0.046 0.0147
Rkr 1.0/{1.0 + exp[(v + 55.0)/
75.0]} × 1.0/{1.0 +
exp[(v − 10.0)/30.0]}
1.0/{1.0 + exp[(v + 55.0 +
9)/75.0]} × 1.0/{1.0 +
exp[(v − 10.0)/30.0]}
Reference O’Hara et al. (2011) Huo et al. (2008)
v is membrane potential (mV).
our initial study; Nakamura et al. 2007) are from Janse de
Jonge et al. (2001) and Munro et al. (1991).
Simulating the effects of dofetilide
An IKr Markov model (Romero et al. 2014) was
incorporated into the O’Hara–Rudy human ventricular
action potential (AP) model (O’Hara et al. 2011) to
simulate the effects of dofetilide on IKr.
Simulated G604S mutation
Experiments suggest that the G604S hERG pore loop
mutation alters the current amplitude and the gating of the
wild-type (WT) hERG channel. We simulated the mutant
IKr (heterozygous channel: 50% each of WT and G604S)
by modifying the conductance ofWT current and also the
kinetics of WT channel from the O’Hara–Rudy human
model (O’Hara et al. 2011) based on the experimental
data shown in Table 4.
Simulation of sympathetic nervous system: protein
kinase A effects
Wesimulated the effects of 1μMISOon IcaL, Iks, Ikb, INa, Jrel,
Jup, troponinand INak, according toO’Hara&Rudy (2012).
In addition, progesterone and testosterone affect the
conductance of IKs, but have no distinguishable effects on
its kinetics under SNS stimulations. To model the effects
of progesterone and testosterone on IKs, we modified GKs
by scaling factors as indicated by the experimental data. In
order tonotoverestimate the combinedeffects ofDHTand
SNS on IKs, we assumed that the combined effects reached
a saturating level that is less than an additive effect, as was
shown for progesterone. If the combination were additive,
we would expect even more protection by testosterone in
the setting of SNS.
Testosterone and SNS stimulation effects on IKs, ICaL
and the kinetics of the latter are shown in Table 5.
DHT application during SNS stimulation affects the
kinetics of ICa,L: the activation curve is less steep and
is shifted to depolarized potentials compared to base-
line (half-maximal activation shifted V1/2 = 5 mV
and slope factor k = 0.4 for DHT 100 nmol l−1).
The inactivation curve is shifted in the hyperpolarized
direction and becomes steeper compared to baseline
(half-maximal inactivation shiftedV1/2 = −2.1 mV and
slope factor k = −0.3).
In the simulations, we shifted the ICa,L activation
and inactivation curves by the same amount as above
experimental data suggested to account for the different
dosages of progesterone (see Table A2). Also the
experimentally observed ICa,L current reduction factor is
0.82 for [DHT] = 35 nM (Table 5). We used experimental
data from 100 nM of DHT because 35 nM is a maximally
stimulating dose of DHT on ICa,L (Table 5). We then
multiplied the scaling factors for IKs and ICa,L when DHT
is applied (see Table 5). Simulated results are in good
agreement with experimental data shown in Fig. 1. The
effects of progesterone on ICa,L and IKs are shown in
Appendix Table A2. Note that the ISO dose (0.1 μM) used
in the experiments is a maximally stimulating dose.
Pacing protocol for arousal arrhythmia conditions
Cells were paced for 400 beats at basic cycle length
(BCL) 1200 ms with no protein kinase A (PKA) effects,
and followed by 10 beats (BCL = 800 ms) with PKA
application.
Transmural tissue simulations
We simulated a transmural fibre composed of 360
ventricular cells (x = y = 100 μm) connected by
resistances to simulate gap junctions (Faber&Rudy, 2000).
The fibre contains an endocardial region (cells 1–160) and
epicardial region (cells 161–360), with a linear decrease
in APD as indicated by experimental data (Glukhov et al.
2010; Lou et al. 2011). GKr was used as the index value
of endocardium in cell no. 1, and the index value of
epicardium in cell no. 360. In the female model, GKr
was monotonically increased from 0.036 to 0.042. In the
male model, GKr was linearly increased from 0.046 to
0.05. AP simulations were carried out in epi-/endocardial
cells by changing various ion channel conductances and
gap-junctions (Yang & Clancy, 2012). The fibre was paced
at BCL = 1200 ms for 500 beats and simulated arousal
arrhythmia conditions (see above).
We simulated a heterogeneous 2D cardiac tissue
composedof 360by440 cellswithx=y=150μm.The
tissue contains an endocardial region (fibres 1–160) and
epicardial region (fibres 161–360). Channel conductance
and gap-junction parameters are the same as in the
one-dimensional simulations. Current flow is described
by the following equation:
∂V(x, y, t)
∂t
= Dx ∂
2V(x, y, t)
∂x2
+ Dy ∂
2V(x, y, t)
∂y2
− I ion − I stim
Cm
C© 2017 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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Table 5. Simulated effects of testosterone (DHT) on IKs and ICa,L
Channel DHT DHT (SNS stimulation)
10 nM 35 nM 35 nM
IKs 1.38 1.4 3.52
ICaL 0.94 0.82 2.05
Kinetics of ICaL No effects dss = 1.0/{1.0 + exp[(−(v + 3.94 + 16 − 5.0))/4.63]}
fss = 1.0/{1.0 + exp[(v + 19.58 + 8.0 + 2.1)/3.396]}
Reference Bai et al. (2005) Table 1
v is membrane potential (mV).
whereV is themembrane potential, x and y are distances in
the longitudinal and transverse directions, respectively,Dx
and Dy are diffusion coefficients in the x and y directions,
Cm is membrane capacitance (Cm = 1), and Istim is
180 mA cm−2 for the first 0.5 ms. We also incorporated
anisotropic effects by settingDx andDy such that the ratio
of conduction velocities is 1:2 (Young & Panfilov, 2010).
The tissuewasfirst paced for 500beats atBCL=1000ms
on theentire lengthofone sideof tissueprior toapplication
of SNS, and then the 501th beat was paced on the top left
corner in an endocardial region with no PKA effects at
BCL = 1000 ms followed by PKA additions in the next
beat paced in the same region.
Pseudo-ECG computation. Extracellular unipolar poten-
tials (e) generated by the fibre in an extensivemedium of
conductivity σe, were computed from the transmembrane
potential Vm using the integral expression as in Gima &
Rudy (2002).
In one dimension:
e(x
′) = a
2σi
4σe
∫
(−∇Vm) •
[
∇ 1
r
]
dx
r = [(x − x′)2]1/2
In two dimensions:
e(x
′, y ′) = a
2σi
4σe
∫
(−∇Vm) •
[
∇ 1
r
]
dxdy
r = [(x − x′)2 + (y − y ′)2]1/2
where V is the spatial gradient of Vm, a is the radius
of the fibre, σi is the intracellular conductivity, σe is the
extracellular conductivity, and r is the distance from a
source point (x, y) to a field point (x′, y′).e was computed
at an ‘electrode’ site 2.0 cm away from the distal end along
the fibre axis.
Action potential duration mapping. We reconstructed
‘human transmural myocardial’ based on data describing
transmural action potential heterogeneity mapped from
normal human left ventricle (Glukhov et al. 2010)
(Fig. 8A). First, the O’Hara–Rudy humanmodel was used
to generate a GKr lookup table corresponding to APD80.
Next, an experimental 2DAPD80 map (100× 100–Fig. 8A)
wasused to create a 2DGKr mapusing theGKr lookup table.
Then the two-dimensional GKr values (100 × 100) were
used to simulate APD80.We paced the female heart at 1Hz
and modified the length of APD80 to match the clinically
observed QT intervals 400 ms (Stramba-Badiale et al.
1997; Ebert et al. 1998; Nakagawa et al. 2005). We
then constructed a 3D wedge of 100 by 100 by 1 with
x = y = 200 μm and z = 500 μm using this APD
mapping data. Current flow is described by the following
equation:
∂V(x, y, z, t)
∂t
= Dx ∂
2V(x, y, z, t)
∂x2
+ Dy ∂
2V(x, y, z, t)
∂y2
+Dz ∂
2V(x, y, z, t)
∂z2
+ − I ion − I stim
Cm
where V is the membrane potential, Dx, Dy and Dz are
diffusion coefficients in the x, y and z directions, and
Istim is 150 mA cm−2 for 0.5 ms. We also incorporated
anisotropic effects by setting Dx, Dy and Dz such that the
ratio of conduction velocities is 2:4:1 (Young & Panfilov,
2010).
Structural model development
The SWISS-MODEL homology modelling program
(Kopp & Schwede, 2004) was used for the development
of the hERG model from the available Eag1 channel
cryo-EM structure (PDB ID 5K7L), determined at 3.78 A˚
resolution (Model 1). A multiple sequence alignment was
performed using the CLUSTALW algorithm (Thompson
et al. 1994). Protein models were generated from the
alignment in a stepwise manner. The conserved back-
bone coordinates of the template were preserved in the
final model (Wang et al. 2016). The gap regions in the
sequence alignment were modelled either from a loop
library or through a conformational space search using
constrained element methods. The scoring function used
for determining side chain conformations was derived
from a backbone-dependent rotamer library (Benkert
et al. 2011) that accounts for favourable interactions,
C© 2017 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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such as hydrogen bonds and disulfide bridges, as well as
unfavourable close contacts. A more detailed description
of protocols and sequence alignments used for hERG
model generation were provided previously (Durdagi
et al. 2012; Anwar-Mohamed et al. 2014; Wang et al.
2016).
Model 1 was used to study all interactions between
E2 and extracellular pore loop residues in both WT and
G604S mutant. While this model provides a new template
for understanding the effects of mutations in this region,
it contains a pore domain in the closed state, and the
molecular volume available for binding inside the pore
is far too small to accommodate any of the common
blockers. Therefore, to study the potential interactions
between the channel and hERG blockers, we used a pre-
viously developed and experimentally validated model of
the hERG pore in the open state (Durdagi et al. 2012;
Anwar-Mohamed et al. 2014) based on the Kv1.2 X-ray
crystal structure (PDB ID 2A79), determined at 2.9 A˚
resolution (Model 2). It is important to stress that this
previously published model of the hERG pore displays
remarkable structural conservation with the published
Eag1 structure for residues critical for drug binding (T623,
S624, Y652 and F656), with major differences in the
pore loop region far away from the common intra-cavity
binding site (Wang et al. 2016). To further refine both
Model 1 andModel 2 of the hERG channel, we performed
molecular dynamics (MD) simulations with a protocol
described below.
Molecular docking and MD simulations
First, themolecular structure of oestradiol (E2)was down-
loaded from the ZINC database (Irwin et al. 2012) and
the partial charges were recalculated using the GAAMP
protocol (Huang & Roux, 2013). Next, molecular docking
was performed using the Glide-XP (extra precision) and
Induced Fit Docking (IFD) modules of the Maestro suite
from Schro¨dinger (Gabrielsen et al. 2012) for dofetilide
and E2 binding toModel 1 andModel 2. A molecular grid
of 36 A˚ × 36 A˚ × 36 A˚ was used to map binding pockets
on the hERG surface. We followed the recommended
protocol for docking of dofetilide and oestradiol including
the following steps: (1) constrained minimization of the
receptor with a root mean square deviation cutoff of
0.18 A˚; (2) initial Glide docking of each ligand using
soft potentials; (3) refinement of the derived docking
poses (i.e. minimization of the protein receptor site within
20 A˚ of the ligand-bound area) with Schrodinger’s Prime
module; and (4) Glide re-docking of the protein–ligand
complexes. Clustering analysis was used to evaluate the
docking poses in both the poor loop (using Model
1), and intracellular cavity site (using Model 2). The
top-scoring pose from each docking simulation was used
for MD simulations. We considered five hERG–substrate
complexes in total, including hERG–E2 (pore loop
WT), hERG–E2 (pore loop G604S), hERG–E2 (cavity),
hERG–dofetilide (cavity), and hERG–E2–dofetilide
(cavity). CHARMM-GUI (Jo et al. 2008) was used to pre-
pareprotein–dipalmitoylphosphatidylcholine lipidbilayer
complexes solvated in 150 mM KCl aqueous solution
using CHARMM-36 force field and TIP3P water model
(Jorgensen et al. 1983; MacKerell et al. 1998; Noskov
et al. 2004; Noskov & Roux, 2008; Klauda et al. 2010;
Best et al. 2012). The remaining parameters for oestradiol
were generated with MATCH (Yesselman et al. 2012). The
molecular parameters for a neutral form of dofetilide
were reported previously (Wang et al. 2016). The fully
assembled systems were equilibrated for 10 ns using
NAMD2.10 (Phillips et al. 2005), and production runs
were then performed for 50 ns for E2 binding to the
WT and G604S mutant pore loop site (Model 1). Both
dofetilide and E2 binding to the intracellular cavity
(Model 2) were studied with 100 ns MD simulations.
All production runs were performed under a constant
temperature andpressure (NPT) ensemble,with apressure
of 1 atm and temperature of 315.15 K. Long-range electro-
static interactions were treated by the particle mesh Ewald
(PME) algorithm (Essmann et al. 1995). Non-bonded
interactions were switched off at 10–12 A˚. The systems
were simulated with a time step of 2 fs under periodic
orthorhombic boundary conditions. The ensembles of
frames obtained from various MD simulations were used
for the calculation of binding enthalpies using a previously
developed protocol based on continuum solvent model
enthalpies (Robertson et al. 2008).
Results
Combined effects of sex, SNS and IKr channel
blocking drugs
Clinical and experimental studies have shown that females
are especially susceptible to QT-interval prolongation by
IKr blocking drugs (Kurokawa et al. 2008). This finding
may partially explain why females are more prone to
drug-induced arrhythmias (Makkar et al. 1993; Lehmann
et al. 1996). Hence, we tested the combined effects of
hormones and the IKr channel blocker dofetilide on
SNS-induced arrhythmia triggers.
Dofetilide is a prototype of the pro-arrhythmic class –
associated with hERG block, QT prolongation and TdP
(Van Opstal et al. 2001). We recently developed a
detailed kinetically based model of the hERG blocker
dofetilde by extending the consensus five-state Markov
chain model that includes three closed states (C3,
C2 and C1), a conducting open state (O) and an
inactivation state (I) (Romero et al. 2014). The expanded
IKr model that includes dofetilide interactions was
incorporated into the O’Hara–Rudy model of the
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human ventricular action potential (AP) (O’Hara et al.
2011).
The dofetilide model, described and validated in
detail previously (Romero et al. 2014), includes the
experimentally observed 70-fold preferential binding to
the inactivated state relative to the open state (Perrin
et al. 2008) and mimics the clinically observed 16%
prolongation of the QT interval produced by the
therapeutic dose 8.22 nM (Demolis et al. 1996). The
effects of the female hormones 17β-oestradiol (E2) and
progesterone (Pg), themale hormone dihydrotestosterone
(DHT) and sex-specific genomic-based differences in
expression of key cardiac channels on human action
potentials from this study and O’Hara et al. (2011) and
Yang & Clancy (2012) were also incorporated to develop
female and male models as described in more details in
Methods above.
We utilized these male and female models and added
the combined effects of dofetilide with acute effects of
β-adrenergic stimulation by isoproterenol to predict the
combined effects of (1) genomic-based differences in
expression of key cardiac channels, (2) human physio-
logical concentrations of sex hormones, (3) an inherited
long-QT syndrome and (4) sympathetic arousal that
includes an increase in pacing rate.
Simulation of cell-level effects of sex-based arousal
arrhythmias
Figure 2 (upper panels) shows the predicted effects
of dofetilide to generate arrhythmia triggers in single
simulated myocytes in the early follicular phase of
the menstrual cycle (Fig. 2A), the late follicular phase
(Fig. 2B), the luteal phase (Fig. 2C) and in the presence of
testosterone (Fig. 2D). Shown are the predicted effects of
sex differences and SNS in the setting of acquired long-QT
syndrome, modelled as the application of dofetilide.
Action potentials are shown following pacing for 400
paced beats at a cycle length of 1200ms in single simulated
endocardial cells. The 399th and 400th paced beats are
shown, afterwhich SNSwas acutely applied and the pacing
cycle length increased to 800 ms to mimic SNS effects
on heart rate. Upon acute SNS application arrhythmia
triggers were observed in single myocytes (upper panels)
in both the early follicular phase of the menstrual cycle
(Fig. 2A) and in the late follicular phase (Fig. 2B). The
follicular phases of the menstrual cycle when oestradiol
is highest were especially vulnerable. Progesterone was
apparently protective during the luteal phase (Fig. 2C)
as was the presence of testosterone (Fig. 2D). These
simulations predict that the female cardiac myocytes in
the presence of a hERG blocker exhibit arrhythmogenic
rhythms upon SNS. When no drug or SNS was
applied, no arrhythmogenic rhythms were observed
(Appendix Fig. A1).
Simulation of tissue-level effects of sex-based arousal
arrhythmias
We also explored the effects of sex-based differences in
the setting of acquired long-QT syndrome type 2 and
acute SNS in a one-dimensional transmural strand of
coupled cells comprising epicardial to endocardial regions
(detailed explanation of construction of the tissue is in
Methods).
Figure 2 (middle and lower panels) illustrates
the predicted sex differences in tissue arrhythmia
vulnerability during acquired long-QT following arousal
by SNS. Simulations in one-dimensional transmural tissue
composed of coupled cells (360 cells) are shown in the
presence of 10 nM dofetilide during the early follicular
phase of the menstrual cycle (Fig. 2A). Time is shown
on the x-axis and voltage on the z-axis in the middle
panels. The corresponding electrograms are shown in
each panel below the space-time plots. Simulated action
potentials (APs) are shown following pacing for 400beats
at 1200 ms pacing cycle length. The last 3 beats are shown
and then SNS was acutely applied and the cycle length
was increased to 800 ms. As shown in Fig. 2B, the late
follicular phases of the menstrual cycle where oestradiol is
highest exhibits an arrhythmogenic rhythm triggered by
the acute application of SNS. An early afterdepolarization
(EAD) initiated in the endocardial region (in the late
follicular case shown in Fig. 2B) generates a sufficient
source current to drive full action potential initiation in
the downstream excitable (repolarized) epicardial region.
The second depolarization during the endocardial EAD
results in a self-sustaining oscillation derived from a
spatially discordant alternans that zig-zags back and forth
to re-excite downstream or upstream cells. The excitatory
signal is runaway, as it is a self-generating oscillation in
the form of a one-dimensional reentry. Both an increase
in progesterone during the luteal phase (Fig. 2C) and
testosterone in the male tissue (Fig. 2D) were predicted
to protect against SNS arrhythmia provocation.
We next tested the vulnerability to arrhythmia induced
by SNS in models of acquired long-QT syndrome in
simulated human male and female two-dimensional
tissues as shown in Fig. 3 by simulating a heterogeneous
cardiac tissue containing an endocardial region (tissue
columns 1 to 160) and an epicardial region (tissue columns
161 to 360) based on recordings from human tissue
(Glukhov et al. 2010; Lou et al. 2011) also incorporating
anisotropic effects as described in detail inMethods above.
Following pacing for 500 beats (s1) at BCL = 1000 ms
along the entire endocardial length, SNS was then applied
with an additional stimulus (s2) afterwhich the simulation
ran for 3000 ms without any additional stimulation.
Figure 3 shows voltage snapshots in time as indicated
prior to and following the application of SNS in
two-dimensional tissuemodels. The simulatedmale tissue
C© 2017 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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Figure 2. Sex-based differences in human cardiac electrophysiology predicted in the setting of acquired
long-QT syndrome induced by dofetilide
Single cell action potentials were simulated before and during simulated arousal via sympathetic stimulation
following pretreatment with dofetilide (top panel A–D). Transmural 1-dimensional tissue models and pseudo-ECGs
were simulated before and during SNS. The pseudo ECG is shown beneath the tissue simulation in each panel.
A, simulated combined effects of oestradiol and progesterone on female tissues during the early follicular phase
of the menstrual cycle. B, simulated combined effects of oestradiol and progesterone on female tissues during
the late follicular phase of the menstrual cycle. C, simulated combined effects of oestradiol and progesterone on
female tissues during the luteal phase of the menstrual cycle. D, simulated effect of testosterone on male tissue
during SNS.
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with testosterone is shown in Fig. 3D. The 500th paced
beat is shown prior to application of SNS. The pre-
sence of dofetilide resulted in SNS-induced self generated
arrhythmias in the female simulated tissues during the
early follicular (Fig. 3A) and late follicular (Fig. 3B) phases
of themenstrual cycle. The time course of single cell action
potentials from two points in space (labelled as ‘a’ and
‘b’) in the simulated 2D tissue and the computed electro-
grams are shown in the right columns. Site ‘a’ under-
goes two consecutive stimuli (indicated as ‘1st and ‘2nd’)
at 10 ms and 1010 ms. Sympathetic activation occurs
concurrently with the second stimulus. However, the site
of activation (near ‘a’) becomes a site of reactivation via
back-propagating action potential conducted from down-
stream tissue (near ‘b’). The tissue near site ‘a’ then
re-excites site ‘b’, which continues in a feedback loop
(observed as an oscillation on the computed electrogram),
during which site ‘a’ maintains depolarization and serves
as a persistent current source.
When progesterone was high during the luteal phase
(Fig. 3C), no arrhythmias were predicted. We also
did not observe any arrhythmias in the male model
when testosterone was present (Fig. 3D). Application of
dofetilide led to development of spontaneous oscillations
in the female only – suggesting vulnerability to arrhythmia
in the follicular phases of the menstrual cycle. The
computed electrograms from the tissue in Fig. 3A and
B exhibit both periodicity and sinusoidal amplitude,
consistent with torsade de pointes type arrhythmias.
Simulation of structural molecular-level effects
of sex-based arousal arrhythmias
The cellular- and tissue-level simulations discussed above
suggest that cardiac ion channel hormone interactions
may constitute an important component of sex-based
arousal arrhythmias with IKr currentmodulation playing a
central role. Experimentally the reduction of IKr resulting
from the action of oestradiol on the hERG channel has
been demonstrated previously (Kurokawa et al. 2008);
however, the molecular-level interactions that underlie
this effect remainuncharacterized.As afirst step to identify
potential binding sites aswell as key stabilizing interactions
between ligand and receptor, we carried out molecular
docking of dofetilide (Fig. 4A) and E2 (Fig. 4B) to the
intra-cellular cavity (IC) of the WT open-state hERG
atomisticmodel (Model 2) developedpreviously (Durdagi
et al. 2011, 2012).
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Figure 3. Female sex is predicted to increase susceptibility to reentrant arrhythmia following acute SNS
stimulation in the setting of acquired long-QT syndrome induced by dofetilide application
A–B, predicted reentrant wave following SNS on female heterogeneous tissue (5.4 cm × 6.6 cm) containing an
endocardial region (tissue columns 1–160) and an epicardial region (tissue columns 161–360) based on recordings
from human tissue, and anisotropic conduction in the presence of female hormones during the early follicular (A),
late follicular (B) and luteal phases (C) of the menstrual cycle. D, no arrhythmia was predicted in male tissue with
35 nM testosterone. Single APs from site ‘a’ and site ‘b’ in the simulated tissues are shown in the middle panels
for each case. Computed electrograms from simulated tissues are shown in the right panels.
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Figure 4. Top scoring docking poses for dofetilide (A and C) and oestradiol (B and C) in the intracellular
cavity (IC) site of hERG
Left panels: pore domain of the hERG open state model and selected frames showing dofetilide (pink) (A), and
E2 (green) (B), binding to the IC. Right panels: average position of dofetilide (A), and E2 (B) shown together with
coordinating residues within 3.5 A˚ for two mapped binding sites. Two dominant binding orientations are shown
in magenta and pink for dofetilide (A), and in green and light-blue for E2 (B). The relative orientation of dofetilide
(pink) and E2 (light-blue), as well as the dominant interacting residues in the hERG IC site, are shown in C.
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The simulations showed that a clustering of dofetilide
poses that provides additional confirmation that dofetilide
interacts with binding pocket for common hERG blockers
(Fig. 4A; Vandenberg et al. 2001; Ficker et al. 2001;Durdagi
et al. 2012). E2 poses and follow-up MD simulations
led to identification of two tentative binding pockets
with favourable binding docking scores for the oestradiol
molecule. The high-affinity site, shown in Fig. 4B, is
located in the intracellular cavity of hERG and over-
laps with a binding pocket for common hERG blockers
including dofetilide (as shown in Fig. 4A) (Durdagi et al.
2012). To provide in-depth analysis of E2 dynamics in
this IC site, we performed 100 ns MD simulations of the
hERG–E2 complex in explicit lipid bilayers. The oestradiol
molecule exhibits substantial flexibility in the IC of hERG,
resulting in a broad distribution of binding enthalpies.
However, most of them are in the −10 to −15 kcal mol−1
range with a mean value around −12 kcal mol−1, which
(without taking into account entropic contribution)
corresponds to low micromolar/potent blocking affinity
(Zachariae et al. 2009; Anwar-Mohamed et al. 2014).
Similar to many other blockers, oestradiol explores both
low- and high-affinity sites in the IC of hERG channel
(Duff et al. 1995; Lees-Miller et al. 2000). Analysis of MD
simulations shows that themost dominant binding pocket
for E2 relies on a combination of π-stacking interactions
of Y652 and F656 rings with an aromatic centroid of E2,
supplemented by hydrogen bondingwith the constellation
of T623/S624 in the pore helix region and S645 in the S6
helix.
The second binding site is defined by the aromatic F656
side-chain, supplemented by a number of hydrophobic
residues including L650 and A653. Y652 is also transiently
involved into coordination of bound oestradiol at this
site. It is apparent that the main determinant of binding
is whether the F656–E2 interaction can be stabilized
by the additional hydrophobic interactions. Kurokawa
et al. (2008) have shown that E2 does not inhibit both
F656T and F656M mutant hERG currents, which is in
agreement with the theoretical results presented here. It is
notable that the relatively small size of oestradiol allows
for another orientation in the binding pocket, where the
bound hormone is oriented along the two distal S6 helices
from adjacent subunits.
The E2 IC binding site is adjacent to that of dofetilide
(see Fig. 4C), suggesting a likely interaction. In fact,
our binding enthalpy calculations from MD simulations
demonstrated that the presence of intracellular cavity
bound E2 leads to a modestly more favourable binding
of dofetilide (by around 1.2 kcal mol−1). Also, the width
of the distribution for dofetilide binding energies is
much narrower with E2 bound to IC of hERG channel.
All this suggests that a presence of E2 can potentially
enhance hERG block by dofetilide, and thus enhance its
proclivity to promote arrhythmia. The combination of
molecular docking,MD simulations and binding enthalpy
computations in conjunction with electrophysiology
data provides consistent evidence for IC blocker action
of E2.
Simulation of cellular-level effects of inherited
sex-based arousal arrhythmias
We next extended the O’Hara–Rudy computational
model (O’Hara et al. 2011) of IKr to include the functional
effects of the cardiac pore loop mutation G604S. As
shown in Fig. 5A and B, the mutant G604S IKr model
was developed by optimizing parameters to experimental
data for current–voltage relationships of peak and tail
currents of G604S IKr recorded from HEK cells. In Fig. 5A
and B, the adjusted, model-generated IKr (lines) is shown
superimposed on experimental IKr records (symbols).
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Figure 5. Simulated and experimentally recorded IKr data
Model-generated IKr (lines) is shown superimposed on experimental
IKr records (symbols with error bars, n = 9) from HEK cells (Huo et al.
2008). A, normalized IKr current–voltage relationship for peak
current for WT (blue) and the hERG-G604S mutation (red). B,
current–voltage relationships from normalized tail currents for WT
(blue) and hERG-G604S mutant channels (red).
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peak current for WT (black) and the hERG-G604S
mutation (red) are shown in panel (A). In panel (B)
there are current–voltage relationships from normalized
tail currents for WT (blue) and hERG-G604S mutant
channels (red).
To determine the sex-based propensity for arousal-
induced arrhythmias, we added the combined effects of
the long-QT syndrome type 2 pore mutation G604S with
acute effects of β-adrenergic stimulation by isoproterenol.
Figure 6 shows the predicted effects on arrhythmia triggers
in single simulated myocytes (upper rows) in female and
male models. These results indicate that the female cells
in the presence of the G604S pore mutation, particularly
in the follicular phases of the menstrual cycle when
oestradiol is highest, are considerably more vulnerable
to the emergence of arrhythmogenic rhythms upon SNS.
Simulation of tissue-level effects of inherited
sex-based arousal arrhythmias
We next explored the effects of sex-based differences in
the setting of inherited long-QT syndrome type 2 pore
mutation G604S and acute SNS in a one-dimensional
transmural strand of coupled cells comprising epicardial
to endocardial regions. The middle panels in Fig. 6A–C
(middle rows) show the sex-based effects in an electrically
coupled female tissue during the early follicular (Fig. 6A),
late follicular (Fig. 6B) and luteal (Fig. 6C) phases of the
menstrual cycle. The male tissue with testosterone pre-
sent is shown in the middle of Fig. 6D. We also computed
electrograms (lower panels) in female and male virtual
tissues (Fig. 6).
Importantly, the simulation shows longer repolari-
zation in the female compared to male tissues following
SNS, consistent with the longstanding observations that
females have longer corrected QT intervals than males
(Jose & Collison, 1970; Huikuri et al. 1996; Burke et al.
1997; Stramba-Badiale et al. 1997; Bidoggia et al. 2000;
Smetana et al. 2002). The prolonged T-wave in females
corresponds to longer APD (as observed in the space–time
plot) and is likely to contribute to the arrhythmogenic
rhythm that emerges in the late follicular phase (Fig. 6B).
Note that the computed electrogram from the tissue in
Fig. 6B exhibits both periodicity and sinusoidal amplitude,
consistent with torsade de pointes type arrhythmias.
We also tested the vulnerability to arrhythmia induced
by SNS with the LQT2 G604S hERG pore mutation
in simulated human male and female two-dimensional
tissues using the same protocol as described in Fig. 3.
Figure 7 shows voltage snapshots in time as indicated
prior to and following the application of SNS in female
tissue in simulated phases corresponding to early follicular
(Fig. 7A), late follicular (Fig. 7B) and luteal (Fig. 7C)phases
of the menstrual cycle. The simulated male tissue with
testosterone is shown in Fig. 7D. Simulations are shown
following pacing from the endocardium for 500 beats at
1000mspacing cycle length.The500thpacedbeat is shown
prior to application of SNS. In the presence of testosterone
(Fig. 7D) or high progesterone (luteal phase in Fig. 7C)
application of SNS is not predicted to be arrhythmia
provoking.
The outcome was starkly different in the female
simulated tissue during the early (Fig. 7A) and late
follicular (Fig. 7B) phases, which following SNS
application developed spontaneous focal arrhythmia
activity – in these cases, the oscillations persist for more
than 3 s. The development of spontaneous sustained
oscillations suggests female vulnerability to arrhythmia
is especially noticeable during the follicular phases of the
menstrual cycle. The computed electrograms from the
simulated tissues are shown in the right panels, clearly
illustrating the abrupt degeneration of the electrical
rhythm following acute SNS in Fig. 7A and B. Notably, in
the absence of either the G604S pore mutation or SNS, no
arrhythmia was observed at the cell (Appendix Fig. A1)
and tissue levels (Appendix Fig. A2).
Finally, because a three-dimensional tissue is a larger
electrotonic sink, we set out to test if the predictions
of female vulnerability to SNS-induced arrhythmia in
the setting of long-QT syndrome type 2 would persist
in higher dimensions. We developed an in silico left
ventricular 3Dwedge reconstruction of the human female
based on the experimental data fromGlukhov et al. (2010)
with the pore loop G604S mutation (Fig. 8). Even in the
3D wedge reconstruction, we observed arousal-induced
spontaneous arrhythmias in the early follicular (Fig. 8A)
and late follicular (Fig. 8B) phases of menstrual cycle
by acute SNS application. Just as in lower dimensions,
the luteal phase is not predicted to be sensitive to SNS
(Fig. 8C).
Ionic mechanisms of arrhythmia vulnerability
in females
We next utilized a component dissection approach to
determine the mechanism of self-generated arrhythmia
triggers in the late follicular phase of the menstrual
cycle. Because PKA activity results in increases in two
inward currents, INa and ICaL, it is difficult to assess
which effect is required to promote arrhythmogenic early
afterdepolarizations. Thus, we selectively blocked the
individual effects of PKA facilitation of INa and ICa, while
maintaining all other effects. The 399th–400th beats (red
arrows) are shown prior to application of SNS. Upon
SNS application, the pacing cycle length was increased
to 800 ms for 100 beats. The last 11 of 100 beats
(BCL= 800ms, under SNS stimulations) are shown in the
right panels. As can be seen in Fig. 9A–C, the blocking PKA
effects on ICaL alone was sufficient to prevent arrhythmia
triggers, which did not emerge even after 100 beats (right
C© 2017 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
4708 P.-C. Yang and others J Physiol 595.14
Early Follicular + G604S mutation Late Follicular + G604S mutation
50
0
−50
−100
50
0
−50
−100
1200 ms 1200 ms
no ISO no ISO
V
m
 (
m
V
)
50
0
−50
−100
V
m
 (
m
V
)
50
0
−50
−100
V
m
 (
m
V
)
V
m
 (
m
V
)
ISO (1 µM) ISO (1 µM)
ISO (1 µM), CL = 800 ms ISO (1 µM), CL = 800 ms
CL = 1200 ms CL = 1200 ms
ENDO ENDO
EPI EPI360
1
C
el
l#
360
1
C
el
l#
Pseudo ECG Pseudo ECG
3600 ms 3600 ms
Luteal phase + G604S mutation DHT 35 nM + G604S mutation
CL = 1200 ms CL = 1200 ms
ISO (1 µM), CL = 800 ms ISO (1 µM), CL = 800 ms
1200 ms 1200 ms
ENDO
EPI
ENDO
EPI360
ce
ll#
 
1
360
C
el
l#
 
1
Pseudo ECG Pseudo ECG
3600 ms 3600 ms
A B
C D
Figure 6. Simulated arousal via sympathetic stimulation in the setting of the G604S mutation causing
inherited long-QT syndrome type 2
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Single cell action potentials are shown at the top of each panel. Transmural 1-dimensional tissue models are shown
in the middle. Time is shown on the x-axis and voltage on the z-axis. The pseudo ECG is shown beneath the tissue
simulation in each panel. A, simulated combined effects of oestradiol and progesterone on female tissues during
the early follicular phase of the menstrual cycle. B, simulated combined effects of oestradiol and progesterone on
female tissues during the late follicular phase of the menstrual cycle. C, simulated combined effects of oestradiol
and progesterone on female tissues during the luteal phase. D, simulated effect of testosterone on male tissue
during SNS.
panels). On the other hand, blocking the effects of PKA
on INa (Fig. 9D–F) did not prevent afterdepolarizations,
which persisted after 100 additional beats (right panels).
Finally, based on recent data from the Salama group,
we examined the effect of increasing INCX (NCX is a
sodium–calcium exchanger) density by 2-fold (Chen et al.
2011) in the epicaridum as shown in Fig. 9G–I. The cell
(Fig. 9G, red line) and coupled tissue (Fig. 9H) exhibited
an exacerbation of proarrhythmia when the INCX density
was increased compared with no changes in INCX (black
line). The effect on the computed electrogram is shown as
a tachycardic rhythm in Fig. 9I.
The explanation for this mechanism can be traced
back in part to the effects of hormones on the ICaL
window current. Progesterone and testosterone cause
a dose-dependent reduction in ICaL window current
(Appendix Fig. A3). During the follicular phases of
the menstrual cycle, low progesterone (2.5 nM) does
not sufficiently reduce the ICaL window current, which
when combined with reduced hERG current due to
long-QT syndrome type 2 mutations or drugs, resulted
in increased susceptibility to EADs in female myocytes
during the follicular phase. Our simulations suggest that
EADs were initiated by a perfect storm of PKA effects,
acute hormone effects on ICaL and IKr suppression by
the long-QT syndrome type 2 mutation or dofetilide
(Appendix Fig. A4). At the tissue level, there is an
additional effect in the female of reduced gap junction
conductance, incorporated in our model based on the
observation of reduced Cx43 in female versusmale hearts
(Gaborit et al. 2010; Yang & Clancy, 2012). Reduced gap
junction coupling (Xie et al. 2010) in the female relative
to male (Appendix Table A1) is predicted to promote the
development of EADs, by creating a source–sinkmismatch
that allows for triggered activity in groupsof cells to initiate
reentry in tissue.
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Figure 7. Female sex is predicted to increase susceptibility to reentrant arrhythmia following acute SNS
stimulation in the setting of inherited LQT2 syndrome
A–C, predicted reentrant wave following SNS on female heterogeneous tissue (5.4 cm × 6.6 cm) containing an
endocardial region (tissue columns 1–160) and an epicardial region (tissue columns 161–360) based on recordings
from human tissue, and anisotropic conduction in the presence of female hormones during the early follicular (A),
late follicular (B) and luteal (C) phases of the menstrual cycle. D, no arrhythmia was predicted in male tissue with
35 nM testosterone. Computed electrograms from simulated tissues are shown in the right panels.
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Structure-based mechanisms of arrhythmia
vulnerability in females
Similar to female predominance of arrhythmia in the
acquired setting, which suggests interactions between
hERG, dofetilide and oestradiol, the female predominance
of inherited arrhythmia linked the the G604S mutations,
suggests that oestradiol may differentially interact with
the mutant hERG channel compared to WT. To probe a
possible molecular mechanism, we utilized the molecular
docking of oestrogen throughout hERG and identified a
second E2 binding site located near the pore loop region
discovered in molecular docking studies performed with
hERG Model 1 (based on the Eag1 template) described
above that involves a number of residues implicated in
gating dynamics. In theWT, this site is exposed to the lipid
bilayer, allowing for easy access to oestradiol (Fig. 10A,
left). The estimated binding affinity of −5.4 kcal mol−1
places E2 in the cohort of weak binders with the estimated
pIC50 (a negative log of 50% inhibition coefficient) <4.5,
comparable to carvedilol block of WT hERG (Durdagi
et al. 2012; Anwar-Mohamed et al. 2014). The MD
simulations of E2 to this binding site show that oestradiol
displays a very broad range of docking poses, and can
rapidly unbind and diffuse away from this low-affinity
site to lipid bilayer. Notably, this site hosts the G604S pore
loop mutation, implicated in female proclivity to arousal
arrhythmia.
This pore loop region appears to be a unique structural
feature of both Eag and Erg channels. MD simulations
suggest that E2 dissociates rapidly from this site inWT and
hence is unlikely to impair function ofWT hERG channel.
In order to investigate how this specific mutation G604S
affects oestradiol binding at the pore loop receptor site, we
mutated ourWThERGmodel accordingly, and again used
molecular docking to identify key binding motifs, shown
in the left and right panels of Fig. 10A for WT and G604S,
respectively.
The MD simulations of the G604S–E2 complex are in
stark contrast with results we obtained for WT channel.
Molecular docking alone results in indistinguishable
binding enthalpies of E2 between WT and G604S:
−6.1 kcal mol−1 vs. −5.4 kcal mol−1, respectively.
However, MD simulations reveal major differences in
conformational dynamics of the pore loop region with
E2 bound in WT and G604S. The clustering of E2 poses
on thehERGextracellular loop inWTandmutant proteins
is shown in Fig. 10B. The RMS fluctuations show that the
mobility/flexibility is much lower when E2 is bound to the
G604S mutant compared to WT (Fig. 10C and Appendix
Fig. A5). When E2 is bound to the G604S mutant, inter-
action remains stable throughout the 50 ns MD, whereas
E2 departs from the WT channel within 20 ns (Fig. 10C).
These results suggest that the pore loop mutation
enhances binding of E2 to the hERG channel. They also
suggest that the enhanced affinity is not due to key inter-
actions between the G604 mutated residue and E2, but
rather the interplaybetweenconformational andflexibility
changes resulting from the mutation. Vandenberg and
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Figure 8. In silico 3D reconstructed human long-QT syndrome type 2 female LVwedge based on Glukhov
et al. (2010) paced with SNS applied
A, reconstruction of a human tissue in silico from normal female explanted heart at a pacing rate of 1 Hz.
Experimental data from normal human left ventricle (Glukhov et al. 2010) shown at the top. B–C, simulated tissue
and pseudo ECG are shown in the bottom panel. In the early follicular (B) and late follicular (C) phases of the
menstrual cycle, SNS application initiates arrhythmia. D, the luteal phase is not predicted to be sensitive to SNS.
APD variability is indicated by the colour scale from long APD80 (red) to short (blue).
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colleagues (Pages et al. 2009) suggested that dynamics and
flexibility of this region is critical for the stability of the
selectivity filter and therefore is expected to play a sub-
stantial role in inactivation dynamics.
Discussion
‘It has only been possible to collect a few figures for
normal women, but so many of these fall outside the
range for normalmen,’ wrote Bazett in his 1920 analysis of
cardiac electrical activity (Bazett, 1997). Nearly a century
has passed since the initial recognition of sex-based
differences in cardiac electrical activity. Yet, even now,
there is a little known about the structural and functional
mechanisms underlying the sex-based differences that
predispose human women to inherited and acquired
long-QT syndrome and associated torsade de pointes
(TdP) arrhythmias (Makkar et al. 1993; Locati et al. 1998;
Salama & Bett, 2014).
Recent experimental studies in a rabbit model of
acquired long-QT syndrome show an increased risk
for arrhythmia and TdP in adult female hearts that
is not observed in pre-pubescent female or adult male
hearts (Liu et al. 2005; Sims et al. 2008). In these
studies, oestrogen-dependent genomic upregulation of
ICa,L and INCX were implicated as possible contributors
to TdP in females (Chen et al. 2011; Yang et al. 2012).
However, these studies did not address the impact of
the autonomic nervous system that apparently impacts
arrhythmia risk in females. Our predictions (Fig. 9) do
support the idea that upregulation of NCX may promote
arrhythmias in females. A population study by Kim et al.
(2010) showed that 82% of observed arousal-induced
arrhythmias occurred in females.
Because sympathetic discharge is a well-recognized
factor in triggering TdP in long-QT syndrome patients,
the combined effects of protein kinase A (PKA)
phosphorylation and sex hormones on ion channels
have recently been studied experimentally (Furukawa
& Kurokawa, 2007; Nakamura et al. 2007; Vaseghi &
Shivkumar, 2008). Progesterone was shown to prevent
PKA-mediated increases in depolarizing current through
the ICa,L, while enhancing the effect of PKA-induced
repolarizing IKs (Nakamura et al. 2007). The net effect
of these two changes is to increase repolarizing current
and reduce APD. In this study, we also included new
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Figure 9. Ionic mechanisms of simulated arousal via sympathetic stimulation in the setting of inherited
or acquired LQT during late follicular phase
Since ISO increased IcaL and INa, here we investigated which current induced EAD. A–C suggested that when we
removed PKA effects on IcaL (B), there was no EAD induction. The 399th–400th (red arrows) are shown prior to
application of SNS. Upon SNS application, the pacing cycle length was increased to 800 ms for 100 beats. The
last 11 beats (BCL = 800 ms, under SNS stimulations) are shown in the right panels. D–F show that eliminating
PKA effects on INa (F) does not suppress EAD-triggered activity. G, INCX densities were increased by 2-fold (Chen
et al. 2011) in epi cell (red line) compared with no changes in INCX (black line). H, transmural 1-dimensional tissue
models with upregulation of NCX in epicardium. I, the pseudo ECG is shown beneath the tissue simulation.
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Figure 10. Oestradiol (E2) binding to a pore loop site of hERG frommolecular docking (A), andmolecular
dynamics (B and C) simulations for wild-type (WT; left) and G604S mutant hERG channel (right)
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A, top scoring docking poses for dofetilide in the pore loop site shown together with coordinating residues within
3.5 A˚ for mapped binding sites. B, E2 positions (shown in green wireframe representation) are mapped from the
frames collected in 40 ns MD for WT and G604S in order to illustrate the conformational space explored by the
ligand in the two systems. It is apparent that E2 is kinetically stabilized (trapped) in the G604S mutant, while it is
unable to bind stably in WT and leaves the binding pocket within 20 ns of MD simulation. C, a G604S mutation
is predicted to enhance stability of the bound E2 (green wireframe) in the binding pocket by controlling binding
site flexibility: the mutation stabilizes the binding site allowing for E2 to remain in the pocket. In contrast, E2
readily leaves binding pocket in the WT hERG protein and diffuses away to the lipid bilayer. Shown are 32 selected
frames from the first 15 ns of molecular dynamics simulation for E2/WT and E2/G604S are shown in different
colours.
data showing the effects of testosterone on the L-type
Ca2+ current in the presence of isoproterenol (Fig. 1).
Just as has been shown for progesterone in a previous
study (Nakamura et al. 2007), testosterone application
blunted the isoproterenol-induced enhancement of the
L-type Ca2+ current. This provides a plausiblemechanism
for testosterone protection against arousal-induced
arrhythmias: a reduction in L-type Ca2+ current allows
for greater rate-dependent shortening of the male action
potential and reduces arrhythmia likelihood.
Women are disproportionately affected by inherited
forms of long-QT syndrome associated with hERG pore
loop mutations as well as by acquired long-QT syndrome,
which results from unintended off-target block of the
major cardiac repolarizing current IKr, encoded by the
hERG gene and characterized by prolongation of the QT
interval. The basis of our study was the hypothesis that
oestrogen will acutely increase arrhythmia vulnerability
and that progesterone will protect against arrhythmia
initiation, especially in the setting of sympathetic
stimulation, a major factor in triggering TdP. This
hypothesis is based on published data showing that
oestrogen interacts directly with the promiscuous hERG
channel, reduces repolarizing IKr current and increases
the rate of channel deactivation (Kurokawa et al.
2008). Kurokawa and co-authors proposed that aromatic
centroid of E2 may be responsible for increasing the
sensitivity of hERG block by E4031 via interaction with
the aromatic side chain of Phe-656 and aromatic rings of
the hERG blocker.
Kurokawa and co-authors have also shown that in the
presence of E2, hERG is markedly more sensitive to block
by drugs and that the concentration of E2 fluctuates
throughout the menstrual cycle, from the peak follicular
phase serum E2 level of 1 nM to 0.7 nM in the luteal
phase (Kurokawa et al. 2008). Since E2 has dramatic effects
on sensitivity to hERG block within this range, it stands
to reason that susceptibility to drug-induced arrhythmia
by hERG block may also vary through the menstrual
cycle, but the exact mechanism of potential concomitant
effects on common blocker action remain unknown. The
predictions from molecular modelling studies based on
bacterial KcsA andMthK (Perry et al. 2004; Stansfeld et al.
2007) channels or themammalian channelKv1.2 (Durdagi
et al. 2010; Stary et al. 2010) concur with the experimental
findings that have revealed two key residues responsible
for drug stabilization in the hERG1 cavity, e.g. Y652 and
F656 (Lees-Miller et al. 2000; Mitcheson et al. 2000; Ficker
et al. 2001; Vandenberg et al. 2001; Fernandez et al. 2004;
Durdagi et al. 2012).Model studies reproduced this feature
in studies of hERG blockers such as dofetilide, KN-93 and
other common high-affinity blockers (Durdagi et al. 2011,
2012).
Previous studies of high- and low-affinity blockers such
as dofetilide, astemizole and haloperidole suggest that an
‘ideal’ high-affinity blocker should simultaneously inter-
act with F656, Y652 and/or A653 at the inner cavity of
hERG, and form hydrogen bonds with T623 and S624
from the pore helix (Mitcheson et al. 2000; Lees-Miller
et al. 2000; Ficker et al. 2001; Fernandez et al. 2004;Durdagi
et al. 2011, 2012;Vandenberg et al. 2001). The binding data
collected from our MD simulations shown in Fig. 4 end-
orse the presence of these sites accommodating favourable
and synergistic binding of both E2 and dofetilide. The
distribution of binding energies and binding pockets for
E2 and dofetilide suggest a plausible scenario of hormone
modification of common blocker action. In the intra-
cellular cavity (IC) of hERG, the presence of E2 only
modestly enhances the binding affinity of dofetilide;
however, there is less variance in the distribution of
binding energies for dofetilide with E2 bound. That
is, bound hormone stabilizes the high-affinity site for
dofetilide and virtually eliminates binding to a low-affinity
site.
The hERG channel exhibits a high degree of homology
with the Eag1 channel, the structure of which has recently
been determined (Whicher & MacKinnon, 2016). The
availability of the Eag1 structure provided us with a
new and unique structural template for understanding
arrhythmia-associated mutations.
A key feature revealed by the structure is the extended
‘extracellular turret’. Indeed, this region is home to the
G406S mutation studied here, and we found that it
appears to provide a pocket for oestrogen binding that
is stabilized by the mutation. The new structural data
allowed the revelation of interactions between physio-
logically important and tightly controlled lipophilic sub-
stances such as E2 and functionally important lipid-facing
regions of the hERG channel. It is also predicted in our
study that E2 binding may impact the channel through
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two distinct mechanisms. The first mechanism involves
a high-affinity binding site that is located near the pore
loop region, which is involved channel kinetics and plays
an important role in normal physiology. Post-adolescent
females show more than nine times the number of
arousal-triggered arrhythmias than men of the same age
group, and arousal-triggered events are more than twice
as high among female patients exhibitingmutations in the
pore loop region of hERG, but not mutations in other
regions (Kim et al. 2010). We hypothesized that pore
loopmutationsmaymodify the oestrogen interactionwith
hERG. Indeed, this notion is corroborated by our findings,
which suggest that E2 binds with higher affinity in the
hERG model with the pore loop G604S mutation.
The second mechanism involves another high-affinity
binding site for E2, located in the intracellular cavity of
hERG in the vicinity of Y652, a residue crucial for the
channel block. This suggests that E2 may enhance the
actionof commonblockers, such as dofetilide, as predicted
by our binding enthalpy calculations. It is also probable
that the mechanisms co-exist, depending on the physio-
logically driven concentration fluctuations of E2 in cell
membranes. Establishing a connection between these two
mechanisms of action is a goal for our future studies.
The present study focuses on the role that changes
in sympathetic tone play in triggering arousal-induced
arrhythmia. It should be noted that there are also
sex-related differences in parasympathetic tone that
we have not considered in this study. It has been
demonstrated that parasympathetic influence on cardiac
function is greater in females than males (Dart et al.
2002). Elevated parasympathetic tone, which is associated
with greater heart rate variability, was found to be
greater in premenopausal women and postmenopausal
women receiving hormone replacement therapy,
suggesting that oestrogen may be responsible (Liu et al.
2003). Because of this, it is conceivable that abrupt
termination of parasympathetic input also contributes to
arousal-induced arrhythmias, since vagal withdrawal has
been shown to result in an increase in cAMP production
that potentiates sympathetic responses (Belevych et al.
2001; Harvey & Belevych, 2003).
Limitations of the current study
There are several limitations in our study. While
the O’Hara–Rudy model was extensively validated in
reproducing experimentally observed rate dependence in
single cells, themodeloverestimates the ratedependenceof
APD in human tissue compared to experiments reported
by Franz et al. (1988). We also did not consider the pre-
sence of other prevalent disease states such as diabetes that
have a sex difference component (Shimoni et al. 2009).
An important limitation in the interpretation of
structural modes of E2 binding to hERG is an absence of
a high-resolution experimental structure of the channel.
In this study, we resorted to using homology models
in our simulations, which depend on the availability of
high-resolution experimental template structures, in the
desired conformational state, and with high sequence
identity. We therefore chose suitable templates (Eag1
and Kv1.2) for our models that allowed us to study
two distinct regions of interest in hERG: the pore loop
region and the intracellular cavity. While we recognize
the inherent limitations of using homology models, there
is, importantly, remarkable consensus for crucial drug
binding sites in both models that we used.
We also acknowledge that our molecular simulation
approach returns only binding enthalpy distributions,
which, in the absence of the entropic and diffusion
data that are crucial for quantitative drug–channel
thermodynamic and kinetic predictions, are not able to
unambiguously predict quantitative indices of current
inhibition. We are planning further studies now with
mapping free energy and diffusion profiles to compute
‘on’ and ‘off’ channel-hormone interaction rates for the
kinetic models to evaluate impact of hormone binding on
the channel current blockade. Our current study reveals
the first mechanistic models of how E2 could potentially
enhance hERG blockade. However, dofetilide is known to
exhibit several modes of binding to hERG and our first
simulation here suggests that oestradiol helps to stabilize
one of them in the open pore of the hERG channel.
Furthermore, based on work of Sanguinetti (Chen et al.
2002) and studies that followed (Rodriguez-Menchaca
et al. 2006; Stork et al. 2007; Lees-Miller et al. 2015),
we may expect a state-dependent blockade by dofetilide
and thus will need to evaluate binding of a hormone to
different states. Whether these are separate mechanisms
or ones that can coexist are the questions we intend to
study in the near future. This work will refine different
E2 binding modes, their affinities and kinetics through a
combination of experimental and computational studies.
The computationalmodelling and simulation approach
has allowed us to explore the complex non-linear inter-
play between processes that underlie differences in risk
to acquired long-QT-dependent arrhythmias. They also
allow us to predict the ‘perfect storm’ of hormone
concentration, IKr derangement and sympathetic
stimulation that may explain one mechanism of increased
proclivity to arousal arrhythmia in females. The results
of this study suggest specific therapeutic anti-arrhythmic
strategies for women with long-QT syndrome, which may
include specific hormone replacement therapy, as well
as suggested and counter-indicated drugs. To realize the
most basic biological mechanisms underlying sex-based
differences in long-QT syndrome risk and susceptibility
to TdP arrhythmias is the critical first step to set the stage
for specific sex-based diagnosis and therapeutic targeting
of cardiac disease.
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Appendix: Simulation of genomic sex
steroid hormone effects
Female hearts had reduced expressionof theK(C)-channel
subunits HERG, minK, Kir2.3, Kv1.4, KChIP2, SUR2,
and Kir6.2, and lower mRNA expression of connexin43
and phospho-lamban compared to males. Experiments
demonstrated concurrence of changes between gene and
protein expression forHERG,minK,Kv1.4,KChIP2, IRX5,
Nav1.5 and connexin43 (Nav1.5-expression showed no
male–female differences) (Gaborit et al. 2010). Details are
given in Table A1.
Table A1. Sex-based differences in ion channel subunit expression from non-diseased ventricles used in the computational model
Epi EndoChannels in
the model Gene Male Female Male Female
IKs KvLQT1 104.2 77.5 90.4 109.6
MinK(KCNE1) 13.6 ± 1.4
m∗↑
7.3 ± 5
f∗↓
11.9 ± 4.2
m
∗∗↑
5.8 ± 2.6
f
∗∗↓
Ratio 1.04 ± 0.04 0.87 ± 0.14 1 ± 0.12 0.83 ± 0.07
Functions Co-expression of KvLQT1 and MinK shifts the voltage to more positive voltages. Also it increases
amplitude of expressed current. Only MinK shows significant differences between male and
female. The stoichiometry of KCNE1:KCNQ1 in IKs channels is a fixed 2:4 (Nakajo et al. 2010). The
ratio was calculated by modified the 1/3 of current activity depending on MinK.
IKr hERG(Kv11.1) 179.5 ± 6.4
m∗↑
144.2 ± 41.1
f∗↓
164.8 ± 54.9
↑
130.5 ± 65
↓
Ratio 1.09 ± 0.039 0.875 ± 0.25 1 ± 0.33 0.79 ± 0.39
IK1 Kir2.1 94.5 93.8 104.1 79.7
Kir2.2 111.1 115.3 93.6 104.5
Kir2.3 91.2 ± 31.8
m∗↑
21.4 ± 10.6
f∗↓
92.7 ± 26.8
m∗∗↑
55.2 ± 21.5
f∗∗↓
Ratio 0.98 ± 0.12 0.74 ± 0.04 1 ± 0.09 0.86 ± 0.077
Functions Kir2.x channels mediate cardiac IK1 (Dhamoon et al. 2004); however, only Kir2.3 is significantly
different. The ratio was calculated by changing the 1/3 of Kir2.3 channel activity.
Ito,s Kv1.4 12.1 ± 3.3
m∗↑
5.4 ± 3.8
f∗ ↓
20.2 ± 4.0
m
∗∗ ↑
12.9 ± 5.2
f
∗∗ ↓
Ratio 0.6 ± 0.16 0.26 ± 0.19 1 ± 0.2 0.64 ± 0.26
INaK ATPasea1 207.7 ± 67
m∗ ↓
513.4 ± 134.6
f∗ ↑
269.0 ± 70.3
m∗∗ ↓
622.5 ± 287.7
f
∗∗ ↑
a3 1481 ± 267
m∗ ↑
917.8 ± 416.7
f∗↓
1547.6 ± 299.5
m∗∗↑
1014.2 ± 294.5
f∗∗ ↓
Ratio 0.94 ± 0.18 0.7 ± 0.3 1.0 ± 0.2 0.79 ± 0.26
Functions a3 is about 2-fold more active than a1 in LV (Gaborit et al. 2007). The ratio was calculated
depending on 1/3 of a1 and 2/3 of a3.
IpCa PMCA1 31.7 46.4 44.1 48.1
PMCA4 377.0 ± 57.2
m∗ ↓
682.1 ± 265.9
f∗ ↑
426.8 ± 116.6
m↓
685.2 ± 379.7
f↑
Ratio 0.88 ± 0.13 1.6 ± 0.6 1.± 0.27 1.6± 0.89
Functions PMCA1 serves a critical housekeeping function that is required for the maintenance of basic cellular
function (Brini, 2009). PMCA4 nearly ubiquitous distribution has a similar role to that of PMCA1.
PMCA4 was reported much more activity than PMCA1 in LV (Gaborit et al. 2007), and there are
no differences between sexes in PMCA1. The ratio was calculated depended only on the PMCA4.
Iup SERCA2 4850.5 ± 146
m∗ ↓
6728.4 ± 1876.1
f∗ ↑
3410.4 ± 982.1
m
3921.9 ± 1760.7
f
Ratio 1.42 ± 0.04 1.97 ± 0.55 1 ± 0.28 1.15 ± 0.5
Calmodulin CALM1 1329.5 991.9 879.8 1122.7
CALM3 1326.9 ± 220
m∗ ↓
1955.5 ± 372.2
f∗ ↑
1206.9 ± 187.7
m
∗∗ ↓
1600.5 ± 242.9
f∗∗ ↑
Ratio 1.07 ± 0.12 1.41 ± 0.2 1 ± 0.1 1.21 ± 0.14
Functions CALM3 is more activity than CALM1 (2-fold in LV) (Gaborit et al. 2007). The ratio was obtained by
changing the 2/3 of activity depends on CALM3.
(Continued)
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Table A1. Continued
Epi EndoChannels in
the model Gene Male Female Male Female
Gap-junction Cx43 1124.1 ± 357
m∗ ↑
728.6 ± 274.1
f∗ ↓
1196.3 ± 311.7
m∗∗ ↑
810.9 ± 333.9
f∗∗ ↓
Ratio 0.94 ± 0.3 0.61 ± 0.24 1.0 ± 0.26 0.68 ± 0.28
Ratios are relative to the male endocardial cell as we published previously (Yang & Clancy, 2012). ∗Differences between male and
female in Epi is statistically significant. ∗∗Differences between male and female in Endo are statistically significant.
Table A2. Simulated effects of progesterone on IKs and ICa,L
Channel Progesterone (baseline) Progesterone (SNS stimulations)
2.5 nM 40.6 nM 2.5 nM 40.6 nM
IKs 1.19 1.4 3.488 3.52
ICaL 1.0 1.0 2.5 2.5
Kinetics of ICaL No effects dss = 1.0/{1.0 + exp[(−(v +
3.94 + 16 − 1.5))/4.73]}
fss = 1.0/{1.0 + exp[(v + 19.58 +
8.0 + 1.7)/3.596]}
dss = 1.0/{1.0 + exp[(−(v + 3.94 +
16−4.4))/5.23]}
fss = 1.0/{1.0 + exp[(v + 19.58 +
8.0 + 3.7)/3.096]}
Reference Nakamura et al. (2007)
ControlA B C D ControlDofetilide 10 nM G604S Mutation
Early Follicular phase
Late Follicular phase Late Follicular phase Late Follicular phase Late Follicular phase
Luteal phase Luteal phase Luteal phase Luteal phase
DHT 35 nM DHT 35 nMDHT 35 nM DHT 35 nM
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Figure A1. Single cell action potentials during simulated arousal via sympathetic stimulation in the
setting of control or the G604S mutation
Action potentials are shown following pacing for 400 paced beats at a cycle length of 1000 ms in single simulated
endocardial cells. The 399th and 400th paced beats are shown, after the pacing frequency was increased to 800ms
with or without SNS applied. A, control case with no SNS applications. B, dofetilide with no SNS applications. C,
G604S mutation with no SNS applications. D, control case with SNS applied after 400 beats.
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Figure A2. Human cardiac
electrophysiology predicted in female late
follicular phase (no mutation) transmural
tissue models and simulated pseudo-ECGs
during SNS
A, simulated 1-dimensional action potentials
(APs) are shown following pacing for
400 beats at 1200 ms pacing frequency. The
398th–400th paced beats are shown prior to
application of SNS. Upon SNS application, the
pacing frequency was increased to 800 ms.
The pseudo ECG is shown beneath the tissue
simulation. Time is shown on the x-axis and
voltage on the z-axis. B, simulated combined
effects of oestradiol and progesterone on
female (no mutation) 2-dimensional tissues
during the late follicular phase of the
menstrual cycle.
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Figure A3. The L-type Ca2+ window current
Steady-state activation (dss) and steady-state inactivation (fss) show the ICaL window current during SNS via ISO. A,
DHT 35 nM (blue lines) indicated a smaller window current compared to progesterone 2.5 nM (red lines). B, high
concentration of progesterone (40.6 nM, red lines) reduced the ICaL window current.
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Figure A4. Ionic mechanisms of simulated arousal via sympathetic stimulation in the setting of the
G604S mutation causing inherited LQT2 syndrome
A, cellular APs. B, intracellular Ca2+ concentration. C, L-type Ca2+ current. D, Na+ current. E, Na+/Ca2+ exchange
current. F, Na+/K+-ATPase (NKA). Same pacing protocol was used as in Fig. 2. The 399th–400th paced beats
(red arrows) are shown prior to application of SNS. Upon SNS application, the pacing frequency was increased to
800 ms for 100 beats. C shows the peak of ICaL was lower in luteal phase or with DHT 35 nM.
C© 2017 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
J Physiol 595.14 Sex-based vulnerability to arousal arrhythmia 4719
4.5
Average-G6045-all subunits-
Average-WT-all subunits-
Cbb-ESTR bound-
Cbb-ESTR bound-
4
3.5
2.5
1.5
0.5
550 560 570 580 590 600 610 620 630 640 650 660 670
Residue Number
R
M
S
F
 (
Å
)
1
2
3
Figure A5. RMS fluctuations per residue
(550–670) for all the subunits of WT (thick
grey line) and G604S (thick red line), E2
bound to WT chain C (black circles) and E2
bound to G604S chain C (red squares)
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Figure A6. Action potential voltage clamp
of simulated arousal via sympathetic
stimulation in the setting of the G604S
mutation causing inherited LQT2 Syndrome
A, cellular action potentials were clamped to the
voltages shown in Fig. A4. B, L-type Ca2+
current. C, intracellular Ca2+ concentration was
clamped to the diastolic rest concentration.
Same pacing protocol was used as in Fig. A4.
When Ca2+-dependent inactivation is reduced
(Ca2+ concentration clamped to diastolic level),
with an EAD voltage clamp protocol, the Ca2+
current is even larger, suggesting a strong effect
of ISO that is usually tempered by
Ca2+-dependent inactivation. In the absence of
ISO, the effect is much smaller (right panels).
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